Skip to main content
Erschienen in:

24.05.2023

The Role of the Microbiome in Erectile Dysfunction

verfasst von: Navid Leelani, Raevti Bole, Prajit Khooblall, Petar Bajic, Scott D. Lundy

Erschienen in: Current Sexual Health Reports | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

There is now growing evidence that the commensal relationship between man and bacteria may be a critical aspect of human health and disease. In this narrative review, we examine the small but growing body of literature exploring the microbiome in comorbidities known to cause sexual dysfunction. We explore the causal relationship between the microbiome and ED. Finally, we identify current gaps in knowledge that may be amenable to future research studies and therapeutics.

Recent Findings

A critical review of the current literature reveals several ways in which the gut microbiome is connected to ED. First, there is strong evidence linking the gut microbiome to known risk factors for ED such as diabetes, hypertension, metabolic syndrome, and obesity. A common theme noted amongst the studies presented in this review article is a shift towards a lower Bacteroidetes to Firmicutes ratio, particularly in obese individuals. The literature also supports a role for the gut microbiome in modulating androgen levels. The data implicating a direct mechanistic effect of the microbiome in ED, however, remains limited. Finally, the gut microbiome does appear to alter PDE5i metabolism and may explain why these drugs are effective in some, but not all, men.

Summary

Despite the limited amount of literature on this emerging topic, recent data does indeed suggest a direct link to the microbiome. This area remains minimally studied ***and much work is needed given the healthcare burden of ED. Further research could provide tools for modulation of the microbiome as part of a multi-pronged approach towards a multifactorial disease like ED.
Literatur
44.
Zurück zum Zitat •• Geng Q, et al. Correlation between gut microbiota diversity and psychogenic erectile dysfunction. Transl Androl Urol. 2021;10:4412–21. https://doi.org/10.21037/tau-21-915. This is one of a very few studies directly examining differences in the microbiome between men who suffer from erectile dysfunction and those who don’t. Specifically, the authors discovered a unique microbial signature in the gut of men with psychogenic erectile dysfunction which is often a diagnosis of exclusion when there is no other explanation for the etiology of erectile dysfunction.CrossRefPubMedPubMedCentral •• Geng Q, et al. Correlation between gut microbiota diversity and psychogenic erectile dysfunction. Transl Androl Urol. 2021;10:4412–21. https://​doi.​org/​10.​21037/​tau-21-915. This is one of a very few studies directly examining differences in the microbiome between men who suffer from erectile dysfunction and those who don’t. Specifically, the authors discovered a unique microbial signature in the gut of men with psychogenic erectile dysfunction which is often a diagnosis of exclusion when there is no other explanation for the etiology of erectile dysfunction.CrossRefPubMedPubMedCentral
46.
Zurück zum Zitat •• Okamoto T, et al. The association between gut microbiome and erectile dysfunction: a community-based cross-sectional study in Japan. Int Urol Nephrol. 2020;52(8):1421–8. https://doi.org/10.1007/s11255-020-02443-9. This is one of a very few studies directly examining differences in the microbiome of men based on their erectile function. The authors were able to highlight diminished and increased presence of specific bacteria in the gut microbiome paving the way for future, more targeted studies.CrossRefPubMed •• Okamoto T, et al. The association between gut microbiome and erectile dysfunction: a community-based cross-sectional study in Japan. Int Urol Nephrol. 2020;52(8):1421–8. https://​doi.​org/​10.​1007/​s11255-020-02443-9. This is one of a very few studies directly examining differences in the microbiome of men based on their erectile function. The authors were able to highlight diminished and increased presence of specific bacteria in the gut microbiome paving the way for future, more targeted studies.CrossRefPubMed
48.
Zurück zum Zitat • Zimmermann M, Zimmermann-Kogadeeva M, Wegmann R, Goodman AL. Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature. 2019;570(7762):462–7. https://doi.org/10.1038/s41586-019-1291-3. This study is important because of it implicates the gut microbiome in the metabolism of phosphodiesterase-5 inhibitors, one of the most commonly used drugs in the treatment of erectile dysfunction. Although a preliminary study, this study may provide an explanation for the difference in efficacy of medical management between men.CrossRefPubMedPubMedCentral • Zimmermann M, Zimmermann-Kogadeeva M, Wegmann R, Goodman AL. Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature. 2019;570(7762):462–7. https://​doi.​org/​10.​1038/​s41586-019-1291-3. This study is important because of it implicates the gut microbiome in the metabolism of phosphodiesterase-5 inhibitors, one of the most commonly used drugs in the treatment of erectile dysfunction. Although a preliminary study, this study may provide an explanation for the difference in efficacy of medical management between men.CrossRefPubMedPubMedCentral
Metadaten
Titel
The Role of the Microbiome in Erectile Dysfunction
verfasst von
Navid Leelani
Raevti Bole
Prajit Khooblall
Petar Bajic
Scott D. Lundy
Publikationsdatum
24.05.2023
Verlag
Springer US
Erschienen in
Current Sexual Health Reports / Ausgabe 3/2023
Print ISSN: 1548-3584
Elektronische ISSN: 1548-3592
DOI
https://doi.org/10.1007/s11930-023-00365-y

Neu im Fachgebiet Urologie

Weniger aggressive Prostatakrebs-Therapie, gleiche Prognose

Erhalten ältere Prostatakrebs-Patienten vor Therapiebeginn ein geriatrisches Assessment, führt dies häufig zu einer Deeskalation der Behandlung – ohne dass ihre Prognose dadurch schlechter würde. Darauf deuten Erfahrungen aus Frankreich hin. 

Hängen Sarkopenie und Harninkontinenz auch bei jüngeren Frauen zusammen?

Ein Zusammenhang zwischen Sarkopenie und Blasenschwäche ist bei älteren Menschen bereits belegt. Ein chinesisches Forschungsteam untersuchte nun, ob auch bei Frauen unter 60 Jahren der Verlust an Muskelmasse mit einem signifikant erhöhten Risiko für Harninkontinenz einhergeht.

Frühzeitige HPV-Impfung schützt auch Männer!

Die HPV-Impfung schützt auch Männer effektiv vor Genitalwarzen, so das Ergebnis einer Literaturstudie. Inwieweit sich mit der Impfung jedoch Karzinome verhindern lassen, vor allem bei Risikogruppen, bleibt unklar.

Subkutanes Pembrolizumab als Therapiealternative?

  • 16.04.2025
  • NSCLC
  • Nachrichten

Pembrolizumab ist unter anderem beim nichtkleinzelligen Bronchialkarzinom (NSCLC) in intravenöser Form zugelassen. Eine subkutane Gabe (s.c.) könnte die Therapie angenehmer und effizienter gestalten. In einer Phase-3-Studie wurde nun untersucht, ob die s.c. Injektion in Kombination mit Chemotherapie der i.v. Therapie bei NSCLC-Erkrankten unterlegen ist.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.